Letter to the Editor
Reply to the letter to the editor regarding “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis, should we anticoagulate?”
Respuesta a la carta al director referida a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
Read
1371
Timeswas read the article
646
Total PDF
725
Total HTML
Share statistics
array:24 [ "pii" => "S2013251423000688" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2023.03.014" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "1073" "copyright" => "Sociedad Española de Nefrología" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2023;43:150-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:20 [ "pii" => "S0211699522001114" "issn" => "02116995" "doi" => "10.1016/j.nefro.2022.05.007" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "1073" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "cor" "cita" => "Nefrologia. 2023;43:150-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Respuesta a la carta al director referida a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "150" "paginaFinal" => "151" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Reply to the letter to editor regarding «Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis, should we anticoagulate?»" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Carmen Sánchez-Gonzalez, José A. Herrero Calvo" "autores" => array:2 [ 0 => array:2 [ "nombre" => "Carmen" "apellidos" => "Sánchez-Gonzalez" ] 1 => array:2 [ "nombre" => "José A." "apellidos" => "Herrero Calvo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2013251423000688" "doi" => "10.1016/j.nefroe.2023.03.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251423000688?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699522001114?idApp=UINPBA000064" "url" => "/02116995/0000004300000001/v1_202301170619/S0211699522001114/v1_202301170619/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2013251423000603" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2023.03.006" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "950" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2023;43:151-2" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on the consensus document on autosomal dominant polycystic kidney disease of the SENefro" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "151" "paginaFinal" => "152" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios sobre el Documento de consenso de poliquistosis renal autosómica dominante de la SENefro" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Ignacio Minguela" "autores" => array:1 [ 0 => array:2 [ "nombre" => "José Ignacio" "apellidos" => "Minguela" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699521001855" "doi" => "10.1016/j.nefro.2021.04.017" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699521001855?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251423000603?idApp=UINPBA000064" "url" => "/20132514/0000004300000001/v1_202306091031/S2013251423000603/v1_202306091031/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2013251423000676" "issn" => "20132514" "doi" => "10.1016/j.nefroe.2023.03.013" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "1067" "copyright" => "Sociedad Española de Nefrología" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Nefrologia (English Version). 2023;43:148-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Comments on “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "148" "paginaFinal" => "150" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Comentarios a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Aleix Cases, José Jesús Broseta, Diana Rodriguez-Espinosa, José Luis Górriz" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Aleix" "apellidos" => "Cases" ] 1 => array:2 [ "nombre" => "José Jesús" "apellidos" => "Broseta" ] 2 => array:2 [ "nombre" => "Diana" "apellidos" => "Rodriguez-Espinosa" ] 3 => array:2 [ "nombre" => "José Luis" "apellidos" => "Górriz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0211699522001059" "doi" => "10.1016/j.nefro.2022.05.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699522001059?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251423000676?idApp=UINPBA000064" "url" => "/20132514/0000004300000001/v1_202306091031/S2013251423000676/v1_202306091031/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Reply to the letter to the editor regarding “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis, should we anticoagulate?”" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "150" "paginaFinal" => "151" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Carmen Sánchez-Gonzalez, Jose A. Herrero Calvo" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Carmen" "apellidos" => "Sánchez-Gonzalez" "email" => array:1 [ 0 => "csanchezgonzalez@salud.madrid.org" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Jose A." "apellidos" => "Herrero Calvo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Hospital Universitario La Princesa, Universidad Autónoma de Madrid, Madrid, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Hospital Universitario Clínico San Carlos, Universidad Complutense de Madrid, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a la carta al director referida a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We would like to thank our colleagues Aleix Cases et al. for the observations described in the letter to the editor sent on the occasion of the publication of the article "Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis, should we anticoagulate?",<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> fundamentally, because we are in total agreement with them and because they have helped to emphasise the conclusions referred to in our original review.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Thus, we agree that tools other than the CHA<span class="elsevierStyleInf">2</span>DS<span class="elsevierStyleInf">2</span>-VASc have recently been proposed to assess bleeding risk in the haemodialysis (HD) population, given the fact that this <span class="elsevierStyleItalic">score</span> has not been shown to be useful in these patients, we did not reference it in our original article. The article referenced in the original review (Ocak et al., reference 40 of the original article) alludes to other <span class="elsevierStyleItalic">scores</span> that could not be validated in chronic kidney disease (CKD) to assess the indication for anticoagulation in these patients either.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Others like the modified CHADS<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> and the <span class="elsevierStyleItalic">dialysis risk score</span>,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> proposed by Vriese et al., also need to be validated in the HD population. Therefore, we emphasise the low predictive value of these scales used in the general population to assess bleeding risk in HD patients, including the classic HAS-BLED scoring system developed to assess the one-year risk of major bleeding in patients with atrial fibrillation and which was developed in 2010 with data from 3978 patients in the <span class="elsevierStyleItalic">Euro Heart Survey.</span><a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The authors of the letter to the editor also agree with us regarding the increased risk of calciphylaxis and peripheral vascular disease that the use of vitamin K antagonists (VKA) produces in HD patients, as demonstrated in the articles that we referenced in the original review. We chose to use the term 'vascular health' to include these and other vascular diseases, but perhaps we should have been more explicit. We appreciate the clarification.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Likewise, we agree on the difficulty of achieving adequate coagulation control in HD patients, as described in the headings "High bleeding risk and lack of efficacy" and "Objective anticoagulation level difficult to control", on discussing the use of VKAs in the HD population. Additionally, the time in the therapeutic range is low in CKD patients, especially in HD patients, a fact that we should be aware of in this population treated with VKA in order to consider all treatment strategies.</p><p id="par0025" class="elsevierStylePara elsevierViewall">We appreciate the mention of another ongoing clinical trial, such as the <span class="elsevierStyleItalic">Danish Warfarin-Dialysis Study Safety and Efficacy of Warfarin in Patients with Atrial Fibrillation on Dialysis</span> (DANWARD) (NCT03862859), which, along with the study mentioned in the original publication (AVK [VKA]-Dial), will provide greater knowledge about the risk-benefit of the use of VKAs in the dialysis population. We would add two further randomised studies with apixaban vs no anticoagulation (EDTA PARIS 2022):<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">□</span><p id="par0030" class="elsevierStylePara elsevierViewall">SACK (Sweden, Norway, Finland, Iceland and Poland), comparing 2.5 mg × 2 tablets apixaban vs no anticoagulation.</p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">□</span><p id="par0035" class="elsevierStylePara elsevierViewall">ApiDP (France), nonrandomised, apixaban 5 mg × 2 vs normal kidney function.</p></li></ul></p><p id="par0040" class="elsevierStylePara elsevierViewall">Fortunately, the initiation of new clinical trials highlights the concern of this issue in the nephrology and medical community in general.</p><p id="par0045" class="elsevierStylePara elsevierViewall">In the letter to the editor, reference is also made to the warfarin-related nephropathy mentioned in the original review, both acute and possible progression of CKD, included in the recent review of Gómez-Fernández et al.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> As we pointed out in reference 103 of the original article (Brodsky et al.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a>), oral anticoagulant nephropathy has also been reported with direct-acting oral anticoagulants,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> as well as the possibility of undiagnosed IgA nephropathy (references 104 and 105 of the original article).<a class="elsevierStyleCrossRefs" href="#bib0040"><span class="elsevierStyleSup">8,9</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">We also agree that percutaneous appendage closure is a therapeutic alternative without risk, as inferred from a recent publication<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> already referenced in the letter.</p><p id="par0055" class="elsevierStylePara elsevierViewall">In summary and to conclude, we would like to express our satisfaction, given that, in the points referred to in the letter to the editor and which, again, we are grateful for, the authors express their agreement with the conclusions we came to in the original review, to which we refer the reader,<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> and they demonstrate the interest in this subject that is aroused, which translates into a dynamism in the studies that are initiated and in the publications that arise in this regard.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Funding</span><p id="par0060" class="elsevierStylePara elsevierViewall">This study received no specific funding from public, private or non-profit organisations.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Conflicts of interest</span><p id="par0065" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Funding" ] 1 => array:2 [ "identificador" => "sec0010" "titulo" => "Conflicts of interest" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:10 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fibrilación auricular-no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Sánchez-González" 1 => "J.A. Herrero Calvo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nefro.2022.01.005" "Revista" => array:2 [ "tituloSerie" => "Nefrología" "fecha" => "2022" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Performance of bleeding risk scores in dialysis patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G. Ocak" 1 => "C. Ramspek" 2 => "M.B. Rookmaaker" 3 => "P.J. Blankestijn" 4 => "M.C. Verhaar" 5 => "J.W.B. Willem" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfy387" "Revista" => array:6 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2019" "volumen" => "34" "paginaInicial" => "1223" "paginaFinal" => "1231" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30608543" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "Y. De Jong" 1 => "E.L. Fu" 2 => "M. van Diepen" 3 => "M. Trevisan" 4 => "K. Szummer" 5 => "F.W. Dekker" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/EURHEARTJ/EHAB059" "Revista" => array:6 [ "tituloSerie" => "Eur Heart J" "fecha" => "2021" "volumen" => "42" "paginaInicial" => "1476" "paginaFinal" => "1485" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33769473" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anticoagulation management in hemodialysis patients with atrial fibrillation: evidence and opinion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.S. De Vriese" 1 => "G. Heine" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/NDT/GFAB060" "Revista" => array:2 [ "tituloSerie" => "Nephrol Dial Transplant" "fecha" => "2021" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "R. Pisters" 1 => "D.A. Lane" 2 => "R. Nieuwlaat" 3 => "C.B. De Vos" 4 => "H.J. Crijns" 5 => "G.Y. Lip" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Chest J" "fecha" => "2010" "volumen" => "138" "paginaInicial" => "1093" "paginaFinal" => "1100" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Oral anticoagulation in chronic kidney disease with atrial fibrillation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "P. Gómez-Fernández" 1 => "A. Martín Santana" 2 => "J.D. Arjona Barrionuevo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/J.NEFRO.2020.08.007" "Revista" => array:6 [ "tituloSerie" => "Nefrologia" "fecha" => "2021" "volumen" => "41" "paginaInicial" => "137" "paginaFinal" => "153" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/36165375" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute kidney injury aggravated by treatment initiation with apixaban: another twist of anticoagulant-related nephropathy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S.V. Brodsky" 1 => "N.S. Mhaskar" 2 => "S. Thiruveedi" 3 => "R. Dhingra" 4 => "S.C. Reuben" 5 => "E. Calomeni" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.23876/j.krcp.2017.36.4.387" "Revista" => array:5 [ "tituloSerie" => "Kidney Res Clin Pract" "fecha" => "2017" "volumen" => "36" "paginaInicial" => "387" "paginaFinal" => "392" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Acute kidney injury and undiagnosed immunoglobulin A nephropathy after dabigatran therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "L. Jansky" 1 => "P. Mukkamala" 2 => "D. Jebakumar" 3 => "A. Rao" 4 => "T.M. Goldson" 5 => "S.N. Forjuoh" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/08998280.2018.1463036" "Revista" => array:6 [ "tituloSerie" => "Proc (Bayl Univ Med Cent)" "fecha" => "2018" "volumen" => "31" "paginaInicial" => "321" "paginaFinal" => "323" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/29904298" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dabigatran-related nephropathy in a patient with undiagnosed IgA nephropathy" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "R. Escoli" 1 => "P. Santos" 2 => "S. Andrade" 3 => "F. Carvalho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1155/2015/298261" "Revista" => array:2 [ "tituloSerie" => "Case Rep Nephrol" "fecha" => "2015" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The association of chronic kidney disease with outcomes following percutaneous left atrial appendage closure" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.R. Ahuja" 1 => "R.W. Ariss" 2 => "S. Nazir" 3 => "Rohit Vvas" 4 => "A.M. Saad" 5 => "M. Macciocca" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/J.JCIN.2021.06.008" "Revista" => array:7 [ "tituloSerie" => "JACC Cardiovasc Interv" "fecha" => "2021" "volumen" => "14" "paginaInicial" => "1830" "paginaFinal" => "1839" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34412801" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002937812019801" "estado" => "S300" "issn" => "00029378" ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000004300000001/v1_202306091031/S2013251423000688/v1_202306091031/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000004300000001/v1_202306091031/S2013251423000688/v1_202306091031/en/main.pdf?idApp=UINPBA000064&text.app=https://www.revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251423000688?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 37 | 28 | 65 |
| 2024 September | 37 | 25 | 62 |
| 2024 August | 52 | 73 | 125 |
| 2024 July | 33 | 27 | 60 |
| 2024 June | 38 | 39 | 77 |
| 2024 May | 45 | 29 | 74 |
| 2024 April | 30 | 38 | 68 |
| 2024 March | 31 | 13 | 44 |
| 2024 February | 37 | 35 | 72 |
| 2024 January | 22 | 25 | 47 |
| 2023 December | 24 | 19 | 43 |
| 2023 November | 38 | 29 | 67 |
| 2023 October | 63 | 43 | 106 |
| 2023 September | 39 | 30 | 69 |
| 2023 August | 34 | 36 | 70 |
| 2023 July | 42 | 47 | 89 |
| 2023 June | 66 | 29 | 95 |
| 2023 May | 27 | 29 | 56 |
| 2023 April | 30 | 52 | 82 |
Show all
